COMPLETED

Brain Vascular and Neurocognitive Health

Talk to us

Conditions

Cognitive DeclineCognitive DysfunctionAlzheimer DiseaseVascular Disease, Peripheralcerebral oxygenationcognitive functionbrain blood flow

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall research objective of this proposal is to determine the acute and chronic impact of transcranial photobiomodulation on indices of cerebral vascular health and neurocognitive function.

Official Title

Brain Vascular and Neurocognitive Health

Quick Facts

Study Start:2024-04-16
Study Completion:2025-09-17
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06497413

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Both men and women between the ages of 18-80 and of any race/ethnicity will be included in this study.
  1. * Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then the investigators may still opt to proceed with data collection.
  2. * Abnormal results from the blood screening will not impact eligibility for the study.
  3. * Individuals with brain injuries/surgeries in a year before the study and individuals who can not provide consent on their own will be excluded from participation.
  4. * Pregnant subjects, women who are breast feeding, and children (i.e. younger than 18) will not be recruited for the study. This will be assessed via self-report.
  5. * If a subject has any allergies to spandex/lycra, the subject will be excluded. However, latex allergies are not contraindicated.
  6. * Individuals with cardiac pacemakers and/or implantable cardioverter defibrillators and individuals with epilepsy will be excluded.

Contacts and Locations

Principal Investigator

Robert M Brothers, PhD
PRINCIPAL_INVESTIGATOR
University of Texas at Arlington

Study Locations (Sites)

UT Arlington - Science and Engineering Innovation and Research Building
Arlington, Texas, 76010
United States

Collaborators and Investigators

Sponsor: The University of Texas at Arlington

  • Robert M Brothers, PhD, PRINCIPAL_INVESTIGATOR, University of Texas at Arlington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-16
Study Completion Date2025-09-17

Study Record Updates

Study Start Date2024-04-16
Study Completion Date2025-09-17

Terms related to this study

Keywords Provided by Researchers

  • cerebral oxygenation
  • cognitive function
  • brain blood flow

Additional Relevant MeSH Terms

  • Cognitive Decline
  • Cognitive Dysfunction
  • Alzheimer Disease
  • Vascular Disease, Peripheral